-
Jul 16, 2021, 4:18 pm104 pts
Ars Technica
Enlarge / The exterior of the headquarters of biotechnology company Biogen in Cambridge, Massachusetts. (credit: Getty | Boston Globe) Biogen's new Alzheimer's drug Aduhelm continues to face opposition after its contentious approval from the Food and Drug Administration last month—which the FDA now says…
Trending Today on Tech News Tube
Tech News Tube is a real time news feed of the latest technology news headlines.
Follow all of the top tech sites in one place, on the web or your mobile device.
Follow all of the top tech sites in one place, on the web or your mobile device.



















